EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:192512 - ABBV-951
| ChEBI ID | CHEBI:192512 |
| ChEBI Name | ABBV-951 |
| Stars | |
| Definition | A mixture comprising of foslevodopa and foscarbidopa, two prodrugs which are metabolized into levodopa and carbidopa. It is developed by Abbvie for the treatment for Parkinson's disease and is administered through a continuous subcutaneous (under-the-skin) infusion via a portable pump. |
| Last Modified | 28 June 2022 |
| Submitter | Adnan |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ABBV-951 (CHEBI:192512) has part foscarbidopa (CHEBI:192511) |
| ABBV-951 (CHEBI:192512) has part foslevodopa (CHEBI:192509) |
| ABBV-951 (CHEBI:192512) is a mixture (CHEBI:60004) |
| Synonyms | Source |
|---|---|
| ABBV951 | ChEBI |
| ABBV 951 | ChEBI |
| foslevodopa/foscarbidopa | ChEBI |
| foscarbidopa/foslevodopa | ChEBI |
| Citations |
|---|